Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 056803/0107 | |
| Pages: | 3 |
| | Recorded: | 07/08/2021 | | |
| Attorney Dkt #: | 7037-106497-01 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17421550
|
Filing Dt:
|
07/08/2021
|
|
Publication #:
|
|
Pub Dt:
|
03/24/2022
| | | | |
|
Title:
|
PHARMACEUTICAL COMPOSITION COMPRISING RUNX3 GENE OR PROTEIN AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF K-RAS MUTANT LUNG CANCER
|
|
|
Assignee
|
|
|
|
|
| 1, CHUNGDAE-RO, SEOWON-GU |
| CHUNGCHEONGBUK-DO |
| CHEONGJU-SI, KOREA, REPUBLIC OF 28644 |
|
|
Correspondence name and address
|
| |
GREGORY K. SCOTT, KLARQUIST SPARKMAN LLP
|
| |
121 SW SALMON STREET
|
| |
SUITE 1600
|
| |
PORTLAND, OR 97204
|
Search Results as of:
06/27/2024 04:02 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
